# Davita Moat

Status: published. Policy: company-analysis-1.

DaVita's established physician relationships, local access and reported multiyear clinical-quality record support plausible relationship and reputation advantages. The supplied passages do not establish durable provider-specific switching barriers, superior relative costs or protected local markets. Pricing outcomes are mixed: annual reimbursement increases coexist with commercial-rate pressure and a realized adverse insurance-mix shift. Improved first-half 2026 operating results demonstrate resilience, but do not independently establish a moat.

## intangible_assets

Established nephrologist relationships and a reported clinical-quality record provide a current referral and reputation advantage; its economic defensibility remains unestablished.

Durability: The issuer reports eleven years of QIP leadership and ten years of Five-Star leadership. Local physician access and joint-venture ownership can support continuity, but neither establishes exclusive referrals or durable pricing premiums.

Risks: Physicians can establish competing facilities, entrants have opportunities for relative ease of entry, and commercial reimbursement remains under pressure. Clinical-quality leadership is reported by the issuer without underlying comparative results.

Invalidation: The candidate advantage would be undermined by loss of reported clinical-quality leadership together with sustained declines in physician referrals or non-acquired treatment volumes attributable to competing providers. Evidence that comparable providers consistently win patients and contracts on equivalent terms would also invalidate economic defensibility.

Competitors: Not established
- [https://www.sec.gov/Archives/edgar/data/927066/000092706626000012/dva-20251231.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706626000012/dva-20251231.htm) · 2026-02-11
- [https://www.sec.gov/Archives/edgar/data/927066/000092706626000108/dva-20260630.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706626000108/dva-20260630.htm) · 2026-08-04
- [https://www.sec.gov/Archives/edgar/data/927066/000092706626000053/dva-20260422.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706626000053/dva-20260422.htm) · 2026-04-22
- [https://www.sec.gov/Archives/edgar/data/927066/000092706625000012/dva-20241231.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706625000012/dva-20241231.htm) · 2025-02-13
- [https://www.sec.gov/Archives/edgar/data/927066/000092706624000013/dva-20231231.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706624000013/dva-20231231.htm) · 2024-02-14
- [https://www.sec.gov/Archives/edgar/data/927066/000092706626000062/dva-20260331.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706626000062/dva-20260331.htm) · 2026-05-05
- [https://www.sec.gov/Archives/edgar/data/927066/000092706626000105/dva63026ex991.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706626000105/dva63026ex991.htm) · 2026-08-04
- [https://www.sec.gov/Archives/edgar/data/927066/000092706626000060/dva33126ex991.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706626000060/dva33126ex991.htm) · 2026-05-05
- [https://www.sec.gov/Archives/edgar/data/927066/000092706626000004/dva-123125ex991.htm](https://www.sec.gov/Archives/edgar/data/927066/000092706626000004/dva-123125ex991.htm) · 2026-02-02

[JSON](https://beanvest.com/stock/dva/moat.json)